Bivalent Transition-State Analogue Inhibitors of Human Glyoxalase I

Organic Letters

Volumn 5, Issue 25, 2003, Pages 4855-4858

  Zheng, Zhe Bin ^a   Creighton, Donald J ^a  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(N 4 CHLOROPHENYL N HYDROXYCARBAMOYL)GLUTATHIONE; (N 4 CHLOROPHENYL N HYDROXYCARBAMOYL)GLUTATHIONE DERIVATIVE; ANTINEOPLASTIC AGENT; DIAMIDE; DIMER; ENZYME INHIBITOR; FUNCTIONAL GROUP; GLUTATHIONE DERIVATIVE; LACTOYLGLUTATHIONE LYASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; COMPETITIVE INHIBITION; CONTROLLED STUDY; CROSS LINKING; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SYNTHESIS; DRUG TARGETING; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME SUBUNIT; HUMAN; HUMAN CELL; MOLECULE; NONHUMAN;

ANIMALS; ANTINEOPLASTIC AGENTS; BINDING SITES; BINDING, COMPETITIVE; ENZYME INHIBITORS; GLUTATHIONE; HUMANS; LACTOYLGLUTATHIONE LYASE; MODELS, MOLECULAR; MOLECULAR STRUCTURE; THIOLESTER HYDROLASES;

EID: 0346422360     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol035917s     Document Type: Article

References (28)

1. Aronsson, A.-C.; Marmstål, E.; Mannervik, B. Biochem. Biophys. Res. Commun. 1978, 81, 1235-1240.
2. Creighton, D. J.; Pourmotabbed, T. In Molecular Structure and Energetics: Principles of Enzyme Activity; Liebman, J. F., Greenberg, A., Eds.; VCH Publishers: 1988; Vol. 9, pp 353-386.
3. Vander Jagt, D. L. In Coenzymes and Cofactors: Glutathione; Dolphin, D., Poulson, P. R., Avramovic, O., Eds.; John Wiley and Sons: New York, 1989; Vol. 3, Part A, pp 597-641.
4. Creighton, D. J.; Hamilton, D. S. Arch. Biochem. Biophys. 2001, 387, 1-10.
5. Richard, J. P. Biochemistry 1991, 30, 4581-4585.
6. White, J. S.; Rees, K. R. Chem. Biol. Interact. 1982, 38, 339-347.
7. Papoulis, A.; Al-Abed, Y.; Bucala, R. Biochemistry 1995, 34, 648-655.
8. Vince, R.; Daluge, S. J. Med. Chem. 1971, 14, 35-37.
9. Creighton, D. J.; Hamilton, D. S.; Kavarana, M. J.; Sharkey, E. M.; Eiseman, J. L. Drugs Future 2000, 25, 385-392.
10. Sharkey, E. M.; O'Neill, H. B.; Kovaleva, E. G.; Kavarana, M. J.; Wang, H.; Creighton, D. J.; Sentz, D. L.; Eiseman, J. L. Cancer Chemother. Pharmacol. 2000, 46, 156-166.
11. Sakamoto, H.; Mashima, T.; Sato, S.; Hashimoto, Y.; Yamori, T.; Tsuruo, T. Clin. Cancer Res. 2001, 7, 2513-2518.
12. (a) Hamilton, D. S.; Creighton, D. J. J. Biol Chem. 1992, 267, 24933-24936.
13. (b) Murthy, N. S. R. K.; Bakeris, T.; Kavarana, M. J.; Hamilton, D. S.; Lan, Y.; Creighton, D. J. J. Med. Chem. 1994, 37, 2161-2166.
14. (c) Kalsi, A.; Kavarana, M. J.; Lu, T.; Whalen, D. L.; Hamilton, D. S.; Creighton, D. J. J. Med. Chem. 2000, 43, 3981-3986.
15. (a) Slon-Usakiewicz, J. J.; Purisima, E.; Tsuda, Y.; Sulea, T.; Pedyczak, A.; Fethuere, M. C.; Yonishi, Y. Biochemistry 1997, 36, 13494-13502 and references therein.
16. (b) Lyon, R. P.; Hill, J. J.; Atkins, W. M. Biochemistry 2003, 42, 10418-10428.
17. Cameron, A. D.; Ridderström, M.; Olin, B.; Kavarana, M. J.; Creighton, D. J.; Mannervik, B. Biochemistry 1999, 38, 13480-13490.
18. Zheng, Z.-B.; Nagai, S.; Iwanami, N.; Kobayashi, A.; Natori, S.; Sankawa, U. Chem. Pharm. Bull. 1999, 47, 777-782.
19. McNaught, A. D.; Wilkinson, A. IUPAC Compendium of Chemical Terminology, 2nd ed.; Blackwell Science, 1997.
20. (a) Kirby, A. J. Adv. Phys. Org. Chem. 1980, 17, 183-278.
21. (b) Morawetz, H.; Goodman, N. Macromolecules 1970, 3, 699-700.
22. (a) Page, M. I.; Jencks, W. P. Proc. Natl. Acad. Sci. U.S.A. 1971, 68, 1678-1683.
23. (b) Jencks, W. P. Adv. Enzymol. 1975, 43, 219-410.
24. (c) Page, M. I. Adv. Chem., Int. Ed. Engl. 1977, 16, 449-459.
25. Creighton, D. J.; Zheng, Z.-B.; Holewinski, R. J.; Hamilton, D. S.; Eiseman, J. L. Biochem. Trans. 2003, 31, 1378-1382.
26. (a) Ridderström, M.; Mannervik, B. Biochem. J. 1996, 316, 1005-1006.
27. (b) Clugston, S. L.; Daub, E.; Kinach, R.; Miedema, D.; Barnard, J. F. J.; Honek, J. F. Gene (Amsterdam) 1997, 186, 103-111.
28. Frickel, E.-M.; Jemth, P.; Widersten, M.; Mannervik, B. J. Biol. Chem. 2001, 276, 1845-1849.